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Abstract: Pre-miRNA-377 is a hairpin-shaped regulatory RNA associated with heart failure. Here, we
use single-molecule optical tweezers to unzip pre-miRNA-377 and study its stability and dynamics.
We show that magnesium ions have a strong stabilizing effect, and that sodium ions stabilize
the hairpin more than potassium ions. The hairpin unfolds in a single step, regardless of buffer
composition. Interestingly, hairpin folding occurs either in a single step (type 1) or through the
formation of intermediates, in multiple steps (type 2) or gradually (type 3). Type 3 occurs only in
the presence of both sodium and magnesium, while type 1 and 2 take place in all buffers, with
type 1 being the most prevalent. By reducing the size of the native hairpin loop from fourteen to
four nucleotides, we demonstrate that the folding heterogeneity originates from the large size of the
hairpin loop. Further, while efficient pre-miRNA-377 binders are lacking, we demonstrate that the
recently developed C2 ligand displays bimodal activity: it enhances the mechanical stability of the
pre-miRNA-377 hairpin and perturbs its folding. The knowledge regarding pre-miRNA stability and
dynamics that we provide is important in understanding its regulatory function and how it can be
modulated to achieve a therapeutic effect, e.g., in heart failure treatment.
Keywords: single-molecule force spectroscopy; optical tweezers; RNA dynamics; RNA folding
heterogeneity; miRNA; pre-miRNA; pre-miRNA-377; heart failure; RNA-ligand interaction
1. Introduction
Precursor microRNAs (pre-miRNAs) are hairpin-shaped precursors of the short
(~22 nt), single-stranded microRNAs (miRNAs; Figure 1A), which are a type of cellu-
lar non-coding RNAs that play a regulatory role in gene expression. MiRNAs hybridize
to certain protein-coding messenger RNAs (mRNAs; Figure 1A), thereby interfering with
their translation in a process called RNA interference (RNAi) [1]. The formation of partially
complementary mRNA–miRNA complexes (Figure 1A) regulates gene expression on the
level of protein synthesis by a repression of mRNA translation [2] or mRNA degradation [3]
and, in a healthy human being, provides homeostasis to the protein abundance. However,
elevated or depleted miRNA levels may cause pathological conditions such as cancer as
well as neurological, autoimmune, and cardiovascular diseases [1].
Recently, miRNA-377 (Figure 1A) has emerged as a key player in heart failure. A
significant increase in miRNA-377 expression was observed in human myocardial tissue
from patients with heart failure compared to nonfailing control hearts [4]. Overexpression
of miRNA-377 was also shown to lead to increased apoptosis in cardiomyocytes [5]. At
the same time, transplantation of human CD34+ stem cells deficient in miRNA-377 into
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the mouse ischemic myocardium was shown to promote their regenerative ability through
angiogenesis (blood vessel formation) [4]. The upregulation of human miRNA-377 re-
presses the synthesis of vascular endothelial growth factor A (VEGFA; Figure 1A) and, as
a consequence, reduces angiogenesis, which has been associated with heart failure [6,7].
Recently, miRNA-377 has also been identified, using mouse models, to function in the
diabetic vascular disease associated with the suppression of the TRAIL cytokine [8]. Heart
failure is a highly lethal and increasingly prevalent disease worldwide [4,9,10]. Due to
structural or functional abnormalities, the heart is unable to pump the blood sufficiently
to meet the needs of the body. With an ageing population and persistently high mortality,
new treatments, especially for acute heart failure, are highly demanded [9].
A very promising perspective proposed in the treatment of diverse cardiovascular
diseases is based on using miRNAs as therapeutic targets, as well as diagnostic biomark-
ers [11]. However, the identification of small-molecule drugs that selectively modulate one
specific upregulated miRNA has been challenging [12]. Moreover, targeting miRNAs by
chemically modified antisense oligonucleotides (anti-miRNAs or AMOs) has been limited
due to low delivery efficiency, poor tissue distribution, and severe side effects [13]. There-
fore, a current R&D approach aims at targeting the structurally more complex pre-miRNAs
instead of miRNAs, by small-molecule binders, which have better cellular permeability
and broader tissue distribution than oligonucleotides [12–14]. This strategy has recently
been applied to the cardiovascular disease therapeutic area, resulting in the development
of the small-molecule ligand TGP-377, able to selectively bind to the A1 and A2 bulges of
the pre-miRNA-377 (Figure 1A) through its C1 and C2 subunits, respectively. TGP-377 has
a dissociation constant, KD, of 190 ± 50 nM [6] and impairs the Dicer enzyme-mediated
biosynthesis of miRNA-377 from pre-miRNA-377 (Figure 1) by binding to the Dicer process-
ing site through the C1 subunit. The C2 subunit provides selectivity for pre-miRNA-377
over pre-miRNA-421, which can also bind C1. C2 has a significantly higher binding affinity
for pre-miRNA-377 (KD = 3.0 ± 0.3 µM) compared to C1 (KD = 65 ± 10 µM); hence, it
has been selected herein as the small-molecule ligand for the development of the optical
tweezer-based pre-miRNA-binding assay (see Figure 1A for C2 structure).
Figure 1. Cont.
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Figure 1. Biosynthesis of miRNA-377 from pre-miRNA-377, which has a role in VEGFA regulation and, hence, in heart
failure disease, the experimental setup, and representative force–distance curve (FDC) data from single-molecule optical
tweezers folding and unfolding measurements of pre-miRNA-377. (A) The single-stranded miRNA-377 is formed from
its precursor molecule, the pre-miRNA-377 hairpin, in an enzymatic reaction catalyzed by the Dicer endoribonuclease. It
can then form a complex with the VEGFA mRNA via Watson–Crick base-pair complementarity of the depicted sequence
fragment (black frame), silencing VEGFA protein expression and suppressing angiogenesis. The blue frame depicts the WT
pre-miRNA-377 construct studied herein. The lowest free energy secondary structures of the human full-length pre-miRNA-
377 and the construct were predicted in UNAFold. Inset, structure of the dimeric TGP-377 ligand with C1 (dark gray),
C2 (framed in orange), and linker (light gray) fragments depicted (adapted from [6]). (B) Our optical tweezers setup for
studying pre-miRNA-377 stability and dynamics. The pre-miRNA-377 molecule (red) was flanked by a short (29 bp) DNA
handle (blue) at each end. The 5′ DNA handle was functionalized with biotin, allowing attachment to a streptavidin-coated
bead, which was held still by a micropipette. The 3′ DNA handle was functionalized with digoxigenin, enabling trapping
of the other end of the construct with an anti-digoxigenin-coated bead held in a movable and force-measuring laser trap.
Drawing is not to scale. (C) A representative force–distance curve (FDC) of the WT pre-miRNA-377 unfolding (red) and
folding (blue) acquired by optical tweezers. At a median force of 14.1 ± 0.3 pN, the pre-miRNA-377 hairpin unfolds (red
arrow—rip; unfolding force—FU) in a single step, increasing the molecule extension and resulting in a force jump. Moving
the laser trap in the opposite direction, and thereby applying a decreasing force leads to pre-miRNA-377 hairpin folding
(blue arrow—zip; folding force—FF) at a median force of 10.1 ± 0.3 pN, also in one step. ∆F is the difference between FU
and FF. The FDC was measured in the high-salt buffer. (D) Histogram of the unfolding (red) and folding (blue) forces of the
WT pre-miRNA-377 in the high-salt buffer.
Previous studies have mainly investigated pre-miRNA-377 as a therapeutic target
in human disease [6]. However, the hairpin stability and dynamics have not been fully
explored yet, neither for pre-miRNA-377 nor for pre-miRNAs in general. In the present
study, we employed single-molecule laser optical tweezers to gain such information. This
force spectroscopy technique has emerged as a powerful tool for probing the conformational
dynamics of nucleic acids due to its high (down to atomic scale) resolution and sensitivity to
rare and transient events [15]. Recent advances in this field have provided new information
on DNA and RNA, complementing ensemble techniques in exploring topics ranging
from structure (e.g., the intermediate and non-native structures) to mechanics (e.g., how
structures are formed and the roles of competing pathways), dynamics (e.g., the intra-
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molecular interactions in folding and misfolding), and function (e.g., the relationship
between dynamics and function) [15]. This is particularly important for RNA, whose
regulatory and stimulatory role is greatly dependent on conformational changes, which
might be both large-scale rearrangements and subtle fluctuations [16,17]. Additionally,
because RNA is prone to degradation at high temperatures (especially in the presence of
magnesium ions), optical tweezers experiments that can be carried out at physiological
temperatures offer a technical advantage over thermal denaturation experiments (e.g., UV
melting) in studying the impact of ions on RNA folding.
Several RNA molecules of various sizes and shapes have been studied by optical
tweezers, from simple RNA hairpins made of an A-form double helix and a hairpin loop
(e.g., P5ab [18] and HIV-1 frameshifting element [19]) to higher-order structures, such as
three-helix junctions, possessing two helices that are coaxially stacked (e.g., P5abc∆A [18]).
The list also includes ribozymes (e.g., the P5abc domain of the Tetrahymena thermophila
ribozyme [18]) and riboswitches (e.g., the add adenine riboswitch from Vibrio vulnificus [20]).
Another popular type of RNA studied by optical tweezers is pseudoknots, formed by
the base-pairing of nucleotides from the hairpin loop with complementary nucleotides
outside that loop (e.g., the SARS coronavirus pseudoknot [21]). However, to the best of
our knowledge, our study presented here is the first investigation of a pre-miRNA using
this approach. Many pre-miRNAs have a large hairpin loop (e.g., the hairpin loop of
pre-miRNA-377 is 14 nt long; Figure 1A), which makes them structurally distinct from
most RNA hairpins studied so far by optical tweezers.
Herein, optical tweezers permitted us to investigate how human pre-miRNA-377
unfolds and folds under physiological conditions. Without using high temperatures or
denaturing agents, but by applying a force to the ends of a single pre-miRNA-377 molecule,
we were able to directly observe its transition from the folded (hairpin) state to the unfolded
state and vice versa. Force and molecule end-to-end distance (extension) were measured
and compared between different buffers, containing sodium (Na+) or potassium (K+) ions
in the presence or absence of magnesium (Mg2+), providing a measure of the pre-miRNA-
377′s mechanical stability in various ionic environments. We also investigated the binding
interactions between pre-miRNA-377 and C2, which allowed us to pinpoint the impact
of the small molecule on the hairpin’s unfolding and folding. With this study, we gained
insight into the pre-miRNA-377 structure–dynamics relationship, which will be beneficial
for further structure–function investigations as well as small-molecule ligand design in
heart failure therapies directed towards the regulation of miRNA-377 levels.
2. Results
2.1. Design of the Pre-miRNA-377 Construct for Optical Tweezers Studies
Pre-miRNAs are ~70 nt long hairpins consisting of a non-perfect stem and a termi-
nal hairpin loop [22,23]. Our lowest free energy secondary structure prediction of the
full-length, 69 nt long, human pre-miRNA-377 (Figure 1A; sequence from RNAcentral,
https://rnacentral.org/rna/URS000075AF10/9606; accessed on 25 February 2021) using
UNAFold (Integrated DNA Technologies; https://eu.idtdna.com/UNAFold; accessed on
25 February 2021) showed that it adopts a hairpin structure with four unpaired regions: an
A:C mismatch, two A-bulges, and a large hairpin loop (Figure 1A, in blue). A previously
reported pre-miRNA-377 structure displays an identical secondary structure of the stem
(the same A:C mismatch and the two A-bulges), but it has a different organization of the
hairpin loop, where a U-bulge and a CG pair are formed [6], instead of the UG and AU
pairs in our prediction (Figure 1A). The latter structure was also obtained by us when
we used the RNAstructure software (https://rna.urmc.rochester.edu/RNAstructureWeb/
Servers/Fold/Fold.html; accessed on 25 February 2021), instead of UNAFold. This com-
parison suggests that while the stem is well-defined, different base-stacking interactions
are possible within the pre-miRNA-377 hairpin loop, leading to alternative conformations.
Irrespective of the tool selected for the secondary structure analysis, all unpaired regions
of the pre-miRNA-377, as well as the cleavage site of the Dicer enzyme (which processes
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pre-miRNAs to RNAi-mediating miRNAs; Figure 1A), are located in the vicinity of the
hairpin loop, whereas the 5′ and 3′ ends of the molecule form a double-helix (Figure 1A).
From a chemical synthesis point of view, long RNA sequences are challenging to produce,
and even more so when they fold back on themselves to form a hairpin [24]. Therefore,
we truncated the full-length pre-miRNA-377 to a 50 nt construct (termed wild type, WT
pre-miRNA-377; Figure 1A, blue frame), reducing the region of the double-helix, but pre-
serving the unpaired regions. To mitigate end-fraying effects, we truncated the molecule at
one of its intrinsic GC pairs. The secondary structure prediction of the WT pre-miRNA-377
construct in UNAFold confirmed that shortening of the stem did not alter the lowest free
energy conformation of the rest of the molecule. The theoretical melting temperature, Tm,
of the WT pre-miRNA-377 obtained using the UNAFold software was 73 ◦C (in 1.0 M
NaCl), indicating high hairpin stability.
For the optical tweezers experiments, we designed the WT pre-miRNA-377 to be
flanked at each end by a double-stranded DNA (dsDNA) only 29 bp in length (see Table S1
for sequence). These dsDNAs served as handles to attach the molecule to beads coated with
streptavidin and anti-digoxigenin, respectively (Figure 1B). To the best of our knowledge,
short DNA handles have never been used before in optical tweezers studies of RNA
molecules, but merely in a few DNA-folding studies [25–28]. The advantage of using short
DNA handles over the more common long handles (typically ~500 bp-a few kbp) [18,29–33]
is that they improve signal-to-noise and make the force changes approximately linear with
extension (Figure 1C), which significantly benefits the data analysis [25].
The identity and conformity of our construct was investigated in initial experiments in
high-salt buffer (1.0 M NaCl; see Figure 1C for a representative force–distance curve, FDC).
In this buffer, the WT pre-miRNA-377 unfolded and folded in single steps at a median force
of 14.1 ± 0.3 pN (FU) and 10.1 ± 0.3 pN (FF), respectively (Figure 1C). The distribution
of both the unfolding and folding forces is shown in Figure 1D. The extension of the WT
pre-miRNA-377 molecule upon force jumps in unfolding (EU = 20.8 ± 0.3 nm) and folding
(EF = 21.0 ± 0.5 nm) corresponded to 50 ± 3 nt, confirming that the synthetized construct
had the anticipated length.
2.2. Impact of Monovalent and Divalent Ions on Pre-miRNA-377 Stability
The FDCs enabled us to perform a detailed biophysical characterization of the pre-
miRNA-377 stability under physiological conditions (Table 1). First, we compared the WT
pre-miRNA-377 hairpin unfolding and folding between sodium and potassium buffers (in
the presence of magnesium). The major type of FDCs (type 1) obtained in the two buffers
is presented in Figure 2A and the corresponding force distribution in Figure S1. We
determined that the pre-miRNA-377 hairpin unfolded at a median force of 13.4 ± 0.4 pN
in the Na+/Mg2+ buffer and 12.7 ± 0.4 pN in the K+/Mg2+ buffer, whereas the folding
force was determined to be 8.9 ± 0.2 pN in the Na+/Mg2+ buffer and 9.0 ± 0.3 pN in the
K+/Mg2+ buffer (Table 1, Figure 2A and Figure S1). Thus, in type 1 FDCs, substituting
sodium with potassium ions resulted in a decrease of the unfolding force, while the folding
force remained the same (statistical analysis can be found in the Supplementary Materials,
Tables S2 and S3). This indicates that potassium ions slightly destabilize the pre-miRNA-377
hairpin compared to the smaller sodium ions.
Table 1. Force (F), extension (E), and force difference (∆F) for the WT pre-miRNA-377 unfolding and folding determined by
optical tweezers in different buffers a.
Buffer FDC N b n c
Unfolding Folding
∆F (pN) d
FU (pN) EU (nm) FF (pN) EF (nm)
High-Salt
Type 1 11/11 765 14.1 ± 0.3 20.8 ± 0.3 10.1 ± 0.3 21.0 ± 0.5 3.9 ± 0.4
Type 2 8/11 42 - - 9.2 ± 0.3 18.2 ± 1.3 4.8 ± 0.3
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Table 1. Cont.
Buffer FDC N b n c
Unfolding Folding
∆F (pN) d
FU (pN) EU (nm) FF (pN) EF (nm)
Na+/Mg2+
Type 1 13/14 545 13.4 ± 0.4 20.9 ± 0.6 8.9 ± 0.2 20.5 ± 0.7 4.2 ± 0.4
Type 2 13/14 246 - - 8.1 ± 0.3 16.3 ± 1.0 5.5 ± 0.5
Type 3 3/14 71 - - 7.1 ± 0.5 - 5.7 ± 0.9
K+/Mg2+
Type 1 8/8 453 12.7 ± 0.4 20.2 ± 0.5 9.0 ± 0.3 20.1 ± 0.7 3.5 ± 0.4
Type 2 8/8 216 - - 8.1 ± 0.4 16.9 ± 1.1 5.0 ± 0.4
Na+
Type 1 5/5 238 11.0 ± 0.6 20.0 ± 0.6 7.4 ± 0.5 19.6 ± 0.9 3.3 ± 0.6
Type 2 5/5 91 - - 7.2 ± 0.4 16.7 ± 1.5 4.3 ± 0.4
a Subscripts U and F refer to unfolding and folding, respectively. The reported values are the median of measurements on three or more
molecules ± standard error of the median (SEM). b Number of molecules showing a given FDC type out of total number of molecules
measured in a specific buffer, indicating that the same molecule can utilize more than one folding pathway in consecutive unfolding–folding
events. c Number of FDCs obtained at a given condition. d ∆F was calculated from Equation (3). Measured at room temperature.
Figure 2. The WT pre-miRNA-377 stability and dynamics. (A) Force–distance curves (FDCs) type 1 of the pre-miRNA-377
hairpin’s single-step unfolding (red) and single-step folding (blue) in different buffers. Representative FDCs are plotted, and
force distributions can be viewed in Figure S1. (B) Three types of pre-miRNA-377 FDCs observed in the Na+/Mg2+ buffer:
type 1 (single-step unfolding and single-step folding), type 2 (single-step unfolding and multi-step folding), and type 3
(single-step unfolding and gradual, i.e., no clear step, folding). Representative FDCs are plotted, and force distributions can
be viewed in Figure S1. (C) The fractions of folding FDCs for pre-miRNA-377 displaying type 1 (gray), type 2 (blue), and
type 3 (red) behavior in different buffers (Na+/Mg2+—plain, K+/Mg2+—striped, Na+—squared).
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Next, to examine the impact of divalent metal ions on the pre-miRNA-377 stability, we
removed magnesium from the Na+/Mg2+ buffer. In the Na+ buffer, hairpin unfolding oc-
curred at 11.0± 0.6 pN and the folding force type 1 was determined to occur at 7.4 ± 0.5 pN
(Table 1, Figure 2A and Figure S1). Hence, both unfolding and folding forces decreased
significantly in the absence of magnesium (Table 1 and Tables S2 and S3), demonstrating
that magnesium has a stabilizing effect on the pre-miRNA-377 hairpin.
2.3. Impact of Monovalent and Divalent Ions on Pre-miRNA-377 Dynamics
Apart from gaining an insight into the hairpin stability, single-molecule force manip-
ulations allowed us to monitor structural transitions within pre-miRNA-377 in real time,
revealing its unfolding and folding pathways (Figure 2B). We found that, regardless of
the buffer composition that we used, unfolding occurred in a single-step rip (Figure 2A,B),
where the pre-miRNA-377 hairpin unfolded directly to its fully unfolded state. However,
unlike the simple unfolding dynamics, folding FDCs had a more complex pattern and
three distinguishable types of curves were found. In addition to a single-step transition as
for the unfolding (type 1), FDCs reflecting multi-step folding (type 2) or even a gradual
folding without a clear step (type 3) were found (Figure 2B). Type 2 and 3 suggest the
formation of intermediates, before the final, full-length hairpin is formed. It is worth noting
that the same molecule can show different types of folding behavior, with or without
intermediates (see the third column in Table 1, e.g., all eight molecules measured in the
K+/Mg2+ buffer displayed both type 1 and type 2 folding). Furthermore, the unfolding
force was independent of folding type (Table 1).
Interestingly, folding behavior type 1 and type 2 were found in all conditions studied,
while type 3 folding was observed only in the Na+/Mg2+ buffer (Figure 2C). Type 1 was
dominant in all ionic environments (63–72%; Figure 2C), and type 2 was also significant
in all physiological buffers (28–32%; Figure 2C). In the high-salt buffer (1.0 M NaCl), we
observed type 2 folding only in approximately 5% of the FDCs. The incidence of type 2
was very similar in all physiological buffers (Figure 2C), suggesting the presence of the
multi-step folding process regardless of the counterion used. Type 3, which is specific to
the buffer containing both sodium and magnesium ions (Na+/Mg2+ buffer; Figure 2C),
accounted for 8% of all FDCs acquired in this buffer.
Analysis of type 2 FDCs showed that the folding transition occurred at the same
median force in the Na+/Mg2+ (8.1 ± 0.3 pN) and K+/Mg2+ (8.1 ± 0.4 pN) buffers, and at a
significantly lower force in the Na+ buffer (7.2 ± 0.4 pN) (Table 1, Figure S1, and Table S3).
In conclusion, for both type 1 and type 2 FDCs, magnesium stabilizes the pre-miRNA-377
upon folding, while the replacement of sodium ions with potassium ions does not alter the
hairpin folding stability.
The force difference between the unfolding and folding transitions (∆F; Figure 1C)
was higher in type 2 and 3 than in type 1 FDCs, regardless of buffer type (Table 1, Figure 2B,
Table S4, and Figure S3B), since the folding force was lower. Remarkably, as can be seen in
Table 1, the folding extension was much lower in type 2 FDCs (~17 ± 1 nm) compared with
type 1 (~20 ± 1 nm), regardless of buffer type, and the distribution of folding extensions
was significantly broader (Figure S2). This is because the single-step folding (type 1) is a
conformational transition that occurs without the formation of intermediates, while folding
by multiple steps (type 2) involves the formation of intermediates. The folding extension
in type 3 FDCs was not determined because, in this case, the molecule gradually folds to
the hairpin structure.
2.4. Loop Mutant of the Pre-miRNA-377
To investigate the origin of the complexity of the pre-miRNA-377 conformational
dynamics, we designed a loop mutant of the WT pre-miRNA-377. The loop mutant (40 nt;
Figure 3A) is identical to the WT pre-miRNA-377 (50 nt; Figure 1A, blue frame) except
that it contains a minimal 4 nt UUUA hairpin loop that substitutes the large, native 14 nt
hairpin loop of the pre-miRNA-377 (Table S1). Unlike the WT pre-miRNA-377, the lowest
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free energy secondary structure prediction of the loop mutant (Figure 3A) was identical
regardless of the software used (UNAFold or RNAstructure), with an identical stem
compared to the WT pre-miRNA-377 (Figure 1A, blue frame vs. Figure 3A), suggesting
that changing the hairpin loop does not affect the conformation of the stem region. The
lowest free energy, ∆G, calculated in UNAFold was −22.4 kcal/mole and −22.2 kcal/mole
for the WT pre-miRNA-377 and the loop mutant, respectively.
Figure 3. The pre-miRNA-377 loop mutant stability and dynamics. (A) The lowest energy secondary structure of the
loop mutant predicted in UNAFold. (B) Force–distance curves (FDCs) of the loop mutant in Na+/Mg2+ buffer: type 1
(one single-step unfolding and folding event) and type 1 with hopping (several single-step unfolding and folding events).
Representative FDCs are plotted; unfolding—red and folding—blue. Force distribution can be viewed in Figure S4A.
(C) Unfolding (FU) and folding (FF) forces in Na+/Mg2+ buffer for the WT pre-miRNA-377 and the loop mutant; type
1—gray, type 2—blue, and type 3—red.
The FDCs of the loop mutant were obtained in the Na+/Mg2+ buffer (N = 9, n = 555)
and typical examples are shown in Figure 3B (force histogram is in Figure S4A). Interest-
ingly, we did not observe type 2 or type 3 FDCs for the loop mutant (Figure 3B,C). All
transitions between hairpin and unfolded conformations exhibited a single-step character
(type 1 FDCs), with a clear rip and a clear zip (Figure 3B). This indicates that the large hair-
pin loop region of the pre-miRNA-377 is the major cause of the complex folding pathways.
Interestingly, several FDCs of the loop mutant showed multiple transitions between the
hairpin and the unfolded form (Figure 3B), which occurred both in unfolding (23% of FDCs)
and in folding (27% of FDCs). Such multiple transitions in molecule extension between
two values within a few piconewtons are termed hopping and indicate bistability [18,34].
Although the loop mutant could hop multiple times during a single pull/relax event, it
unfolded and folded completely (type 1 FDCs) at each occasion, and neither type 2 nor
type 3 were observed (Figure 3C). This type of bistability has previously been attributed to
the free energies of unfolded and folded states being close, and the transition state barrier
between the two states being low [34]. Consequently, we suggest that the reduction of
the native hairpin loop of the pre-miRNA-377 to a tetraloop lowers the activation energy
between the fully unfolded and fully folded states. In turn, since the WT pre-miRNA-377
(Figure 2A,B), unlike the loop mutant (Figure 3B), does not exhibit hopping, but can form
intermediates, the large hairpin loop seems to be a structural constraint that causes the
pre-miRNA-377 to have more local energy minima in which it can be trapped and kept
out of its global thermodynamic equilibrium. In order to quantitatively evaluate the sta-
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bility of the loop mutant, the force at which the first unfolding/folding event occurred
was taken into account for FDCs displaying hopping, similarly to that done before for
canonical stem–loop hairpin systems [35]. The unfolding force values were the same for the
WT pre-miRNA-377 and the loop mutant (13.4 ± 0.4 pN and 13.1 ± 0.4 pN, respectively;
Figure 3C and Table S5), while, in the absence of the extensive loop, the folding force
increased to 11.1 ± 0.5 pN, and was significantly higher than for the WT pre-miRNA-377
(8.9 ± 0.2 pN for type 1 FDCs; Figure 3C and Table S5). Accordingly, the loop mutant’s
∆F (2.0 ± 0.5 pN) was significantly lower than for the WT pre-miRNA-377 (4.2 ± 0.4 pN
for type 1 FDCs; Table S5). As expected, the unfolding and folding extensions of the loop
mutant (16.1 ± 0.6 nm and 16.4 ± 0.5 nm, respectively; see Figure S4B for the extension
histogram) corresponded to 40 ± 2 nt.
2.5. The Effect of C2 Ligand Binding on Pre-miRNA-377 Unfolding and Folding
Having characterized the pre-miRNA-377 alone, we investigated the effect of ligand
binding on pre-miRNA-377 unfolding and folding. For our experiments, we used the
recently developed pre-miRNA-377 ligand: compound 2 (C2, a 4,6-diaminopyrimidine
derivative; Figure 1A) [6]. We observed that some unfolding FDCs recorded in the presence
of the C2 exhibited a rip at 23.7 ± 1.9 pN (N = 5 molecules; Figure 4A,B), which was
significantly higher than the unfolding force determined in the absence of the ligand
under the same experimental conditions (13.4 ± 0.4 pN; Figure 4A,B). This indicates that
C2 stabilizes the pre-miRNA-377 hairpin state. The corresponding folding forces were
7.0 ± 1.6 pN for the ligand-bound state and 8.9 ± 0.2 pN for the most prevalent folding
pathway (type 1) in ligand-less conditions, suggesting that the pre-miRNA-377 folds at
a significantly lower force in the presence of C2. While 63% of FDCs were type 1 for
the ligand-less pre-miRNA-377 (Figure 2C), singe-step folding did not occur at all in the
ligand-bound state. Instead, type 3 (gradual folding) and type 2 (multi-step folding) were
observed (Figure 4A). Thus, we conclude that the C2 ligand binding to the pre-miRNA-377
stabilizes its hairpin conformation (increases FU) and, when unfolded, it inhibits folding
(decreases FF and pushes the system completely to type 2 or type 3). The folding inhibition
is most likely due to an interaction between the C2 ligand and the unfolded pre-miRNA-377
molecule. Although mechanical enhancement effects have been previously observed in
a variety of protein–ligand systems [36] and certain RNA–ligand pairs (e.g., the TERRA
G-quadruplex-cPDS small molecule [37] and the add adenine riboswitch-adenine [20]),
to the best of our knowledge, this is the first case where it has been demonstrated that
ligand binding enhances the mechanical stability of a pre-miRNA hairpin and the first
pre-miRNA-small-molecule binding assay based on optical tweezers in general.
Figure 4. The effect of C2 ligand binding on pre-miRNA-377 unfolding and folding. (A) Representative force–distance
curves (FDCs) showing the unfolding (red) and folding (blue) of the WT pre-miRNA-377 in absence and presence of 12 µM
C2 ligand (orange) in the Na+/Mg2+ buffer. (B) Unfolding force histograms of the WT pre-miRNA-377 without ligand (top)
and in presence of 12 µM C2 (bottom) in the Na+/Mg2+ buffer.
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3. Discussion
MiRNAs are powerful gene regulators, whose features and abundance affect human
health. Knowledge regarding the stability and conformational dynamics of their precursors,
pre-miRNAs, is important for a better understanding of the miRNA biosynthesis and for
designing effective therapies stimulating or inhibiting this process, e.g., to treat cancer as
well as neurological, autoimmune, and cardiovascular diseases.
Our optical tweezers study provides the first insight into the stability and conforma-
tional dynamics of the human pre-miRNA-377, an important therapeutic target in heart
failure. These two features are highly dependent on the ionic strength of the solution as
well as the counterions used [38–41]. The size of cations is important for RNA folding [42]
and potassium is larger than sodium (Pauling ionic radii are 1.33 Å and 0.95 Å, respec-
tively [43]). Moreover, a potassium ion-dependent structural switch from the canonical
stem–loop hairpins to G-quadruplexes has been reported to regulate the Dicer processing of
certain pre-miRNAs (e.g., pre-miRNA-92b) [41]. Here, we determined that pre-miRNA-377
adopts a hairpin structure in the presence of both sodium and potassium ions. Our study
also showed that the mechanical stability of the hairpin increased slightly (0.7 pN) in the
presence of the smaller sodium ions compared to the larger potassium ions (Table 1 and
Table S2). Next, we investigated the role of magnesium ions and observed significantly
stabilized secondary interactions within the pre-miRNA-377 hairpin in the buffer contain-
ing magnesium ions. While the monovalent sodium and potassium ions bind to RNA
hairpins diffusely, the divalent magnesium ions display specificity to unpaired regions in
the RNA structure, such as bulges and internal loops (Figure 1A), with a KD in the mil-
limolar range [38]. Since it is expected that small molecules would interact most strongly
and specifically with the unpaired regions [44], the binding of a drug might require the
displacement of a magnesium counterion. This is particularly interesting in the context of
targeting pre-miRNA-377′s bulges adjacent to the Dicer processing site (Figure 1A) with
small-molecule ligands in the development of a heart failure therapy.
By applying optical tweezers, we were also able to disentangle pre-miRNA-377′s fold-
ing pathways. It is worth noting that duplex stem–loop hairpins of model DNAs [45–47]
and RNAs [18] have previously been reported to possess typically an “all-or-none” behav-
ior, where the molecule unfolds and folds in a single step. We found that such a simple
two-state conformational dynamics model is not applicable to the pre-miRNA-377 hairpin,
and that, instead, folding is a heterogeneous process. In our proposed model (Figure 5), pre-
miRNA-377 unfolding is a two-state process, with the initial state being the pre-miRNA-377
hairpin and the final state being its unfolded counterpart. In folding, multiple pathways
are possible, where, from the unfolded state, the pre-miRNA-377 may fold to a mature
hairpin in a single step (type 1 FDCs) or through partially folded intermediates, which
correspond to type 2 and type 3 FDCs (Figure 2B). Regardless of the ionic environment,
single-step folding (type 1) is the dominant pathway occurring at ~60–70% of events and
multi-step folding (type 2) accounts for ~30% of all FDCs. Folding of type 3, i.e., without a
clear step, rarely occurs (~8% FDCs), and it only takes place in the presence of both sodium
and magnesium ions. The prevalence of folding pathway type 2, as well as the fact that it is
consistently observed in different buffers, indicates that pre-miRNA-377 has the ability to
form partially folded hairpins. Importantly, the same molecule can utilize more than one
folding pathway in the consecutive unfolding–folding events (Table 1), which highlights
the stochastic nature of the folding events.
Interestingly, the folding heterogeneity and the richness of intermediary structures
have not been shown before, neither for the pre-miRNA-377 nor for any other pre-miRNA.
Future studies will likely show whether these features are conserved among pre-miRNAs
and whether they affect gene expression regulation. Recently, the stimulatory function of
programmed ribosomal frameshifting (PRF) structures has been attributed to the hetero-
geneity of their folding dynamics, discriminating the importance of other features, such as
unfolding force and rate or barrier height, for stimulation efficiency [21]. Examples range
from several pseudoknots (including one from the SARS coronavirus) [21] to the HIV-1
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hairpin [19], which all can shift the reading frame of a ribosome on an mRNA in order to
generate an alternate gene product. Conformational plasticity has also been suggested to
play an important role for an adenine riboswitch [13], which is another type of regulatory
RNA structure. Given this literature context, our experimental results call for further
investigations into whether the pre-miRNA’s folding heterogeneity and the presence of the
pre-miRNA hairpin intermediates serve as a regulatory mechanism in RNAi.
Figure 5. Model of pre-miRNA-377 unfolding and folding. (A) The illustrated folded state (hairpin) is the lowest free
energy secondary structure of the pre-miRNA-377 predicted in UNAFold. Partly folded states (intermediates) occurring in
type 2 and type 3 FDCs are drawn schematically (not predicted). (B) With a minimal 4 nt hairpin loop (loop mutant), only
transitions without intermediates between the hairpin and the unfolded state are observed. The folded state of the loop
mutant illustrates the lowest free energy secondary structure predicted in UNAFold.
Our investigation also provides a source of understanding of the observed complexity
in pre-miRNA-377 dynamics. Reducing the size of the pre-miRNA-377′s hairpin loop to
the minimum, four nucleotides, affects its folding pathways. The loop mutant, despite
possessing the two bulges and the internal loop of the WT construct, displays an “all-or-
none” behavior in unzipping and zipping. Based on these comparative studies of the WT
pre-miRNA-377 and its loop mutant, we demonstrate that the folding heterogeneity of the
pre-miRNA-377 originates from its large hairpin loop, which results in the formation of
local energy minima structures and therefore prevents rapid exchange between fully the
folded and fully unfolded states of the molecule.
Finally, we showed for the first time that the optical tweezers technique is powerful for
observing the mechanics of ligand binding to pre-miRNA hairpins. Using the previously
identified C2 ligand [6], we attributed its efficacy to the mechanical stability enhancement
in the pre-miRNA-377 hairpin conformation (C2 shifts the mechanical stability of the
pre-miRNA-377 hairpin by ~2 fold). Hence, the C2 subunit most likely helps the inhibitory
C1 subunit, which has a lower affinity than C2 (KD = 65 ± 10 µM vs. 3.0 ± 0.3 µM,
respectively [6]), to properly accommodate into the A1 bulge (i.e., the C1-binding site).
This is in line with the fact that the KD of the TGP-377 dimer (190± 50 nM [6]) is two orders
of magnitude lower than the KD of C1, indicating a synergistic pre-miRNA-377 binding
effect of linking C1 with C2. Furthermore, we found that C2 has the ability to interact
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with the unfolded pre-miRNA-377, causing an inhibition of its folding. Consequently, we
envisage that a new therapeutic approach targeting conformational transitions between the
hairpin and the unfolded state may emerge in the treatment of the miRNA-377-associated
heart failure and other miRNA-related diseases. Recently, an analogous approach has been
successfully demonstrated for mRNAs, where a small molecule called Synucleozid was
shown to downregulate the levels of the Parkinson’s disease-related α-synuclein protein
by stabilizing the 5′ UTR iron-responsive element (IRE) structure of the α-synuclein-coding
mRNA [48].
Apart from increasing the fundamental knowledge of the secondary structure, stability,
and dynamics of pre-miRNAs and of the structure–dynamics relationship of RNA hairpins,
our study also provides a technical advancement on how to utilize mechanical force ramp
and molecular extension to reveal the transient states of pre-miRNAs under physiologically
relevant conditions. In addition, for the first time, we demonstrate how to use short
dsDNA handles (Table S1) to study RNA by single-molecule optical tweezers to improve
the resolution and simplify data analysis.
Studying pre-miRNAs with single-molecule optical tweezers comes with both ad-
vantages and disadvantages. Thanks to our single-molecule approach, conformational
dynamics could be studied and quantified, allowing us to determine that pre-miRNA-377
forms intermediate structures and that this is due to the large hairpin loop of the molecule.
However, further studies are needed to examine the functional consequences of these
partially folded structures. In particular, it would be interesting to explore whether they
can affect Dicer binding and hence miRNA biosynthesis and/or RNAi-mediated gene
expression regulation. Previous studies on other types of regulatory RNAs, such as PRF
structures and riboswitches, have shown the role of folding heterogeneity in the regulatory
mechanisms of these RNAs [13,19,21]. Therefore, determining the relationship between
pre-miRNA-377 folding and regulatory mechanisms will be very interesting and important.
Other approaches, especially in cellulo and in vivo techniques, may provide a greater in-
sight into this matter, advancing our understanding of miRNA biology as well as possibly
uncovering a new therapeutic strategy to aid in the treatment of heart failure based on the
modulation of pre-miRNA folding.
In summary, single-molecule force spectroscopy has enabled us to gain an insight into
the structure, stability, and conformational dynamics of a therapeutically very relevant
pre-miRNA, the human pre-miRNA-377, which is associated with heart failure. The
study highlights the formation of intermediates upon the folding of the pre-miRNA-377
hairpin. This feature of the pre-miRNA could be very interesting for further studies as it
may potentially function as a regulatory mechanism in RNAi, by analogy to the folding
heterogeneity of other regulatory RNAs reported so far in the literature [13,19,21]. Hence,
it could be relevant in the development of therapies targeting pre-miRNAs with small-
molecule drugs, aiming at tuning the levels of therapeutically relevant proteins, such as
the VEGFA protein (Figure 1A). In addition, we propose that our experimental setup could
be used to study mRNA structures and the stabilization of mRNA folds by small-molecule
binding, e.g., to halt mRNA translation.
4. Materials and Methods
4.1. Pre-miRNA-377 Constructs
Two pre-miRNA-377 constructs were studied: WT pre-miRNA-377 (Figure 1A, blue
frame) and its loop mutant (Figure 3A). They were purchased as 5′-biotinylated DNA–
RNA–DNA hybrid oligonucleotides (see Table S1 for sequences) from Eurogentec, Liège,
Belgium (1.0 µmole scale synthesis, PAGE purification, and MS QC). For details on their
design, see the Results section.
Lyophilized oligonucleotides were dissolved in RNase-free water to a final concentra-
tion of 100 µM. Next, a digoxigenin-labeled tail of ~50 nt was added to the 3′ end of the
oligonucleotide. The 3′ modification was performed at 37 ◦C using Terminal Transferase
kit (Merck, Darmstadt, Germany, Ref. #: 3333566001) and at the digoxigenin-11-dUTP
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(DIG-dUTP; Roche, Rotkreuz, Switzerland, Ref. #: 11558706910) to dATP (Sigma-Aldrich,
Deisenhofen, Germany, Ref. #: 11140965001) ratio of 1:10. The reaction was stopped
after 15 min by adding 0.5 M EDTA, pH 8.0, yielding 5.0 µM oligonucleotide with the 3′
DIG-dUTP tail. The obtained product was purified at room temperature using the RNeasy
Mini Kit (Qiagen, Hilden, Germany, Ref. #: 74104) with 250 mL of ethanol 99.7% for sample
preparation and 30 mL of RNase-free water for elution. The purified tailed oligonucleotide
was subsequently diluted in RNase-free water to a concentration of 2.0 µM. A 29 nt single-
stranded DNA (ssDNA) oligonucleotide complementary to the 5′ and 3′ ssDNA handles
(splint) was added to the purified tailed oligonucleotide at an equimolar ratio. Next, they
were hybridized in a splint buffer (33 mM Tris-HCl, 167 mM NaCl, and 1.0 mM EDTA;
pH 7.4) to obtain the pre-miRNA-377 construct with dsDNA handles, suitable for the
optical tweezers’ measurements. The hybridization was carried out in a PCR machine
and comprised the following steps: heating at 90 ◦C for 1.0 min, cooling from 90–80 ◦C in
10 s, heating at 80 ◦C for 10 s, cooling from 80–40 ◦C at 0.5 ◦C/10 s and from 40–10 ◦C at
0.5 ◦C/20 s. The obtained sample was next diluted in RNase-free water to a concentration
of 0.2 µM. All the sample preparation steps were carried out in RNase-free PCR tubes. The
final sample was aliquoted and stored at −80 ◦C until its use in the experiments.
The molar absorptivity of the oligonucleotides at 260 nm (1,043,300 M−1 cm−1 for the
WT pre-miRNA-377 and 955,300 M−1 cm−1 for the loop mutant) was calculated as the sum of
molar absorptivities of their 5′ DNA (298,200 M−1 cm−1), RNA (446,900 M−1 cm−1 for the WT
pre-miRNA-377 and 358,900 M−1 cm−1 for the loop mutant), and 3′ DNA (298,200 M−1 cm−1)
fragments. For the DNA fragments, the molar absorptivity was approximated by a linear com-
bination of the molar absorptivities of individual nucleotides at 260 nm (εA = 15,300 M−1 cm−1,
εC = 7400 M−1 cm−1, εG = 11,800 M−1 cm−1, εT = 9300 M−1 cm−1 [49]) and multiplied
by 0.9 to account for the base-stacking interactions. For the RNA fragment, the mo-
lar absorptivity was calculated using OligoAnalyzer (Integrated DNA Technologies;
http://eu.idtdna.com/calc/analyzer; accessed on 25 February 2021) and, since the RNA se-
quence yields a double-helix hairpin, the calculated value was multiplied by 0.9 to account
for the base-stacking interactions within the hairpin.
4.2. Buffers
Experiments to validate the synthesis of the sample of interest were performed in
high-salt buffer (10 mM Tris-HCl, 1000 mM NaCl, and 1.0 mM EDTA; pH 7.4), which
yields high resolution in the optical tweezers’ measurements, as a consequence of the
high unfolding force required. Experiments to study the impact of divalent metal ions
(magnesium ions) were performed in Na+/Mg2+ buffer (50 mM Tris-HCl, 140 mM NaCl,
5.0 mM KCl, 1.0 mM EDTA, and 5.0 mM MgCl2; pH 7.4) vs. Na+ buffer (50 mM Tris-HCl,
140 mM NaCl, 5.0 mM KCl, and 1.0 mM EDTA; pH 7.4). Experiments to study the impact
of monovalent salt ions (potassium vs. sodium ions) were performed in Na+/Mg2+ buffer
vs. K+/Mg2+ buffer (50 mM Tris-HCl, 145 mM KCl, 1.0 mM EDTA, and 5.0 mM MgCl2;
pH 7.4).
4.3. Optical Tweezers Measurements of Pre-miRNA-377
Optical tweezers measurements were performed using an in-house built instrument
equipped with two counter-propagating 150 mW, 845 nm laser diodes to form a single
optical trap. Optical fibers were used to direct the laser beams and approximately 5% of
the light was redirected onto a position-sensitive detector (PSD) that recorded the position
of the trap. The remaining light was focused through a water-immersion objective lens
(60X, NA 1.20) to form the trap. Light exiting the trap was collected by an identical
objective lens and directed to a PSD and a photodiode to measure the forces on the
trapped beads. Data were recorded at a frequency of 1.0 kHz. The microfluidic chamber
was mounted between the objectives and moved using a motorized stage. In an optical
tweezers experiment, an anti-digoxigenin-coated bead was captured in the optical trap,
while a streptavidin-coated bead was immobilized by suction at the tip of the micropipette
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(Figure 1B). See Supplementary Materials and Methods for details on the microfluidic
chamber and bead preparation. A tether containing a single pre-miRNA-377 construct was
established between the two beads and the force–distance measurements were performed
by moving the trap at a constant velocity (100 nm/s)—the so-called force–ramp method.
Moving the trap away from the micropipette (pull) caused pre-miRNA unfolding, while
moving it backwards (relax) resulted in pre-miRNA folding. The movement of the trap
changed the distance (D; Figure 1B) between the beads and the force (F) acting on the
hairpin, yielding a force–distance curve (FDC) (Figure 1C). An experiment in a certain
buffer was repeated for several hairpin molecules tethered between different pairs of beads
(Table 1). Tens to hundreds of FDCs were recorded per single molecule (Table 1). Data
are presented as the median ± standard error of the median (SEM), with the size of the
sample, N, being the number of molecules. The frequency distribution of unfolding and
folding forces obtained from multiple acquired FDCs was illustrated in a force histogram
(Figure 1D). All measurements were conducted at room temperature (RT; ca. 23 ± 1 ◦C).
4.4. Optical Tweezers Measurements of the C2 Ligand Binding to the Pre-miRNA-377
The small-molecule ligand named compound 2 (C2; Figure 1A), being a subunit
of the TGP-377 heterodimer [6], was obtained from AstraZeneca, Gothenburg, Sweden.
Experiments with the ligand (12 µM C2) were performed on the WT pre-miRNA-377 in the
same conditions as for the ligand-less experiments, i.e., using the force–ramp method at a
constant velocity of 100 nm/s, in Na+/Mg2+ buffer and at RT.
4.5. Analysis of Optical Tweezers Data
Folding (relax) events were divided into three different types based on their folding
pattern (type 1, 2, or 3) and analyzed separately within each FDC type. The unfolding
and folding forces were observed as sudden jumps in FDCs (Figure 1C) and they were
extracted using custom-made MATLAB programs. The extension of the pre-miRNA-377





where ∆f is the measure of a force jump in an FDC, keff is the effective stiffness of the hairpin
in the folded state (equal to the slope of an FDC), and xd is the double helix diameter. The
xd was modeled as a single bond of length d = 2.0 nm and the mathematical equation for
this model is given by:






where kB is the Boltzmann constant and T is the absolute temperature (298 K). Force
histograms were obtained by combining force values from different FDCs and plotting
their relative frequency for the bin size of 0.5 pN. Extension histograms were obtained in
an analogous way (bin size of 0.5 nm). The errors reported for each bin in the histograms
were obtained by calculating the error of the relative frequency of forces/extensions in
each bin over different bead pairs. The force difference (∆F) was determined as the median
of individual force differences:
∆F = Median (FU − FF)i (3)
where (FU − FF)i is the difference between the unfolding and folding forces of the ith FDC
(Figure 1C). The pre-miRNA-377 unfolding and folding forces obtained from multiple pull
and relax cycles repeated with a given bead pair are dependent on each other, whereas
the forces obtained for different bead pairs are independent. Thus, to account for the
heterogenous data acquired in the optical tweezers experiments, we used the generalized
linear mixed model (GLMM) in our statistical analysis to determine whether there was a
significant difference between unfolding forces determined in different buffers and FDC
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types. The same data treatment was applied for folding forces and force differences. The
GLMM test of statistical significance allowed us to consider the random (stochastic) effects
present in the experiments. The GLMM analysis was performed in the R software [50,51].
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/ijms22169008/s1: Supplementary Materials and Methods: Microfluidic chamber and bead
preparation, Figure S1: Force histograms of the WT pre-miRNA-377 in different buffers, Figure S2:
Extension histograms of the WT pre-miRNA-377 in different buffers, Figure S3: Unfolding and
folding forces, and force difference of the WT pre-miRNA-377 in different buffers, Figure S4: Force
and extension histograms of the pre-miRNA-377 loop mutant in the Na+/Mg2+ buffer, Table S1:
Oligonucleotide sequences used in optical tweezers experiments, Table S2: Statistical analysis of
the WT pre-miRNA-377 unfolding force (FU) in different buffers, Table S3: Statistical analysis of
the WT pre-miRNA-377 folding force (FF) in different buffers for the three types of folding FDCs,
Table S4: Statistical analysis of the WT pre-miRNA-377 force difference (∆F) in different buffers for
the three types of folding FDCs, Table S5: Statistical analysis of the WT pre-miRNA-377 vs. loop
mutant unfolding force (FU), folding force (FF) and force difference (∆F) in the Na+/Mg2+ buffer for
folding FDCs type 1.
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